1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
The outbreak of SARS-CoV-2 virus caused more than 80,155,187 confirmed COVID-19 cases worldwide, which has posed a serious threat to global public health and the economy.The development of vaccines and discovery of novel drugs for COVID-19 are urgently needed.Although the FDA-approved SARS-CoV-2 vaccines has been launched in many countries recently